Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
GMDN
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
class
757ef3c8-10cf-410e-957d-ce8610e31cc5
SAXAGLIPTIN ANHYDROUS Pharmacologic Class Indexing
Class set ID
757ef3c8-10cf-410e-957d-ce8610e31cc5
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class
Mapped DailyMed Labels
#
Label, Manufacturer, Effective table
Label
Manufacturer
Effective
SPL version
These highlights do not include all the information needed to use SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS. SAXAGLIPTIN and METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 2010
Dr.Reddys Laboratories Inc | Dr. Reddys Laboratories Limited (SEZ UNIT)
20260410
7
These highlights do not include all the information needed to use SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS . SAXAGLIPTIN and METFORMIN HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 2010
Mylan Pharmaceuticals Inc.
20260406
6
These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009
Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited
20260127
2
These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS . SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009
Mylan Pharmaceuticals Inc.
20250228
4
These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral use Initial U.S. Approval: 2009
Aurobindo Pharma Limited
20241204
3